Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1000 of 1294 entries
View as:

Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe

Phase: N/A Priority: Normal
NCT ID: NCT01890993 Org: User:
Start: 08/31/13 End: 06/30/14 Due: 06/30/15

A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT01636843 Org: User:
Start: 10/30/12 End: 11/10/14 Due: 11/10/15

Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01650129 Org: User:
Start: 12/13/00 End: 10/18/01 Due: 10/18/02

A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT05873660 Org: User:
Start: 06/12/23 End: 06/24/24 Due: 06/24/25

Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia

Phase: N/A Priority: Normal
NCT ID: NCT01285089 Org: User:
Start: 12/31/10 End: 10/31/13 Due: 10/31/14

Comparison of Two Liraglutide Formulations in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01508897 Org: User:
Start: 05/28/04 End: 06/30/04 Due: 06/30/05

Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00523380 Org: User:
Start: 10/04/07 End: 01/07/09 Due: 01/07/10

A Comparison Between Two Formulations of NN5401 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01125553 Org: User:
Start: 05/31/10 End: 08/31/10 Due: 08/31/11

A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh

Phase: N/A Priority: Normal
NCT ID: NCT01877200 Org: User:
Start: 06/30/13 End: 09/30/13 Due: 09/30/14

Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues

Phase: N/A Priority: Normal
NCT ID: NCT00873639 Org: User:
Start: 04/30/09 End: 11/30/09 Due: 11/30/10

Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01515592 Org: User:
Start: 01/31/06 End: 04/30/06 Due: 04/30/07

Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT00849316 Org: User:
Start: 02/28/09 End: 11/30/09 Due: 11/30/10

A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese

Phase: N/A Priority: Normal
NCT ID: NCT03600480 Org: User:
Start: 07/25/18 End: 06/12/20 Due: 06/12/21

Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01707134 Org: User:
Start: 09/30/97 End: 05/31/00 Due: 05/31/01

A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT04187300 Org: User:
Start: 12/16/19 End: 09/23/20 Due: 09/23/21

A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01392573 Org: User:
Start: 11/28/11 End: 10/04/12 Due: 10/04/13

Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02243098 Org: User:
Start: 09/16/14 End: 04/07/15 Due: 04/07/16

Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01355718 Org: User:
Start: 08/31/11 End: 03/31/13 Due: 03/31/14

Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00518882 Org: User:
Start: 08/31/07 End: 04/30/09 Due: 04/30/10

Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

Phase: N/A Priority: Normal
NCT ID: NCT01734447 Org: User:
Start: 04/30/00 End: 04/30/03 Due: 04/30/04

Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01473953 Org: User:
Start: 10/31/11 End: 03/31/12 Due: 03/31/13

Awareness, Care & Treatment In Obesity Management - An Observation in Switzerland

Phase: N/A Priority: Normal
NCT ID: NCT05232786 Org: User:
Start: 03/08/22 End: 04/08/22 Due: 04/08/23

A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01044108 Org: User:
Start: 01/05/10 End: 09/20/11 Due: 09/20/12

Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00700765 Org: User:
Start: 01/31/08 End: 07/31/08 Due: 07/31/09

A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before

Phase: N/A Priority: Normal
NCT ID: NCT04760626 Org: User:
Start: 03/01/21 End: 08/29/22 Due: 08/29/23